| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis
|
Sanders, Donald B.
|
|
2015
|
12 |
2 |
p. 455-460
|
artikel
|
| 2 |
A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis
|
Sanders, Donald B.
|
|
|
12 |
2 |
p. 455-460
|
artikel
|
| 3 |
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
|
Zach, Neta
|
|
2015
|
12 |
2 |
p. 417-423
|
artikel
|
| 4 |
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
|
Zach, Neta
|
|
|
12 |
2 |
p. 417-423
|
artikel
|
| 5 |
Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease
|
Rosenfeld, Jeffrey
|
|
2015
|
12 |
2 |
p. 317-325
|
artikel
|
| 6 |
Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease
|
Rosenfeld, Jeffrey
|
|
|
12 |
2 |
p. 317-325
|
artikel
|
| 7 |
Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis
|
Rutkove, Seward B.
|
|
2015
|
12 |
2 |
p. 384-393
|
artikel
|
| 8 |
Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis
|
Rutkove, Seward B.
|
|
|
12 |
2 |
p. 384-393
|
artikel
|
| 9 |
Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?
|
Nicholson, Katharine A.
|
|
2015
|
12 |
2 |
p. 376-383
|
artikel
|
| 10 |
Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?
|
Nicholson, Katharine A.
|
|
|
12 |
2 |
p. 376-383
|
artikel
|
| 11 |
Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications
|
Shu, Xiao-Hong
|
|
2015
|
12 |
2 |
p. 491-501
|
artikel
|
| 12 |
Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications
|
Shu, Xiao-Hong
|
|
|
12 |
2 |
p. 491-501
|
artikel
|
| 13 |
Enhanced Retinal Ganglion Cell Survival in Glaucoma by Hypoxic Postconditioning After Disease Onset
|
Gidday, Jeffrey M.
|
|
2014
|
12 |
2 |
p. 502-514
|
artikel
|
| 14 |
Enhanced Retinal Ganglion Cell Survival in Glaucoma by Hypoxic Postconditioning After Disease Onset
|
Gidday, Jeffrey M.
|
|
|
12 |
2 |
p. 502-514
|
artikel
|
| 15 |
Erratum to: TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
|
Scotter, Emma L.
|
|
2015
|
12 |
2 |
p. 515-518
|
artikel
|
| 16 |
Erratum to: TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
|
Scotter, Emma L.
|
|
|
12 |
2 |
p. 515-518
|
artikel
|
| 17 |
Gaps Between Aims and Achievements in Therapeutic Modification of Neuronal Damage (“Neuroprotection”)
|
Wiendl, Heinz
|
|
2015
|
12 |
2 |
p. 449-454
|
artikel
|
| 18 |
Gaps Between Aims and Achievements in Therapeutic Modification of Neuronal Damage (“Neuroprotection”)
|
Wiendl, Heinz
|
|
|
12 |
2 |
p. 449-454
|
artikel
|
| 19 |
Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis
|
Barmada, Sami J.
|
|
2015
|
12 |
2 |
p. 340-351
|
artikel
|
| 20 |
Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis
|
Barmada, Sami J.
|
|
|
12 |
2 |
p. 340-351
|
artikel
|
| 21 |
Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis
|
Verstraete, Esther
|
|
2015
|
12 |
2 |
p. 403-416
|
artikel
|
| 22 |
Neuroimaging as a New Diagnostic Modality in Amyotrophic Lateral Sclerosis
|
Verstraete, Esther
|
|
|
12 |
2 |
p. 403-416
|
artikel
|
| 23 |
Patient-Perceived Outcomes and Quality of Life in ALS
|
Simmons, Zachary
|
|
2014
|
12 |
2 |
p. 394-402
|
artikel
|
| 24 |
Patient-Perceived Outcomes and Quality of Life in ALS
|
Simmons, Zachary
|
|
|
12 |
2 |
p. 394-402
|
artikel
|
| 25 |
Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
|
Hooten, Kristopher G.
|
|
2015
|
12 |
2 |
p. 364-375
|
artikel
|
| 26 |
Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
|
Hooten, Kristopher G.
|
|
|
12 |
2 |
p. 364-375
|
artikel
|
| 27 |
Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis
|
Goutman, Stephen A.
|
|
2015
|
12 |
2 |
p. 428-448
|
artikel
|
| 28 |
Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis
|
Goutman, Stephen A.
|
|
|
12 |
2 |
p. 428-448
|
artikel
|
| 29 |
Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis
|
Tokuda, Eiichi
|
|
2015
|
12 |
2 |
p. 461-476
|
artikel
|
| 30 |
Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis
|
Tokuda, Eiichi
|
|
|
12 |
2 |
p. 461-476
|
artikel
|
| 31 |
Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital
|
Ma, Dongliang
|
|
2015
|
12 |
2 |
p. 477-490
|
artikel
|
| 32 |
Rescue of Methyl-CpG Binding Protein 2 Dysfunction-induced Defects in Newborn Neurons by Pentobarbital
|
Ma, Dongliang
|
|
|
12 |
2 |
p. 477-490
|
artikel
|
| 33 |
RNA-targeted Therapeutics for ALS
|
Reddy, Linga V.
|
|
2015
|
12 |
2 |
p. 424-427
|
artikel
|
| 34 |
RNA-targeted Therapeutics for ALS
|
Reddy, Linga V.
|
|
|
12 |
2 |
p. 424-427
|
artikel
|
| 35 |
Spinal Muscular Atrophy Therapeutics: Where do we Stand?
|
d’Ydewalle, Constantin
|
|
2015
|
12 |
2 |
p. 303-316
|
artikel
|
| 36 |
Spinal Muscular Atrophy Therapeutics: Where do we Stand?
|
d'Ydewalle, Constantin
|
|
|
12 |
2 |
p. 303-316
|
artikel
|
| 37 |
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
|
Scotter, Emma L.
|
|
2015
|
12 |
2 |
p. 352-363
|
artikel
|
| 38 |
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
|
Scotter, Emma L.
|
|
|
12 |
2 |
p. 352-363
|
artikel
|
| 39 |
The Genetics of Spinal Muscular Atrophy: Progress and Challenges
|
Farrar, Michelle A.
|
|
2014
|
12 |
2 |
p. 290-302
|
artikel
|
| 40 |
The Genetics of Spinal Muscular Atrophy: Progress and Challenges
|
Farrar, Michelle A.
|
|
|
12 |
2 |
p. 290-302
|
artikel
|
| 41 |
The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis
|
Cooper-Knock, Johnathan
|
|
2015
|
12 |
2 |
p. 326-339
|
artikel
|
| 42 |
The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis
|
Cooper-Knock, Johnathan
|
|
|
12 |
2 |
p. 326-339
|
artikel
|
| 43 |
The Spectrum of Motor Neuron Diseases: From Childhood Spinal Muscular Atrophy to Adult Amyotrophic Lateral Sclerosis
|
Sakowski, Stacey A.
|
|
2015
|
12 |
2 |
p. 287-289
|
artikel
|
| 44 |
The Spectrum of Motor Neuron Diseases: From Childhood Spinal Muscular Atrophy to Adult Amyotrophic Lateral Sclerosis
|
Sakowski, Stacey A.
|
|
|
12 |
2 |
p. 287-289
|
artikel
|
Tijdschrift beschrijving